Cargando…
Case Report: Molecular Profiling Assists in the Diagnosis and Treatment of Cancer of Unknown Primary
BACKGROUND: For cancer of unknown primary (CUP), non-selective empiric chemotherapy is usually used. However, patients suffering from CUP are generally assumed to have a dismal prognosis with median overall survival of less than 1 year. Therefore, clinicians eagerly await the establishment of effect...
Autores principales: | Yu, Bo, Wang, Qifeng, Liu, Xin, Hu, Silong, Zhou, Liangping, Xu, Qinghua, Sun, Yifeng, Hu, Xichun, Luo, Zhiguo, Zhang, Xiaowei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9005951/ https://www.ncbi.nlm.nih.gov/pubmed/35433426 http://dx.doi.org/10.3389/fonc.2022.723140 |
Ejemplares similares
-
Sentinel node theory helps tracking of primary lesions of cancers of unknown primary
por: Shao, Yilin, et al.
Publicado: (2020) -
Clinicopathological, molecular and prognostic characteristics of cancer of unknown primary in China: An analysis of 1420 cases
por: Qi, Peng, et al.
Publicado: (2022) -
Comprehensive analysis of cancer of unknown primary and recommendation of a histological and immunohistochemical diagnostic strategy from China
por: Ren, Min, et al.
Publicado: (2023) -
90-Gene Expression Profiling for Tissue Origin Diagnosis of Cancer of Unknown Primary
por: Zhang, Yi, et al.
Publicado: (2021) -
Bone metastasis pattern of cancer patients with bone metastasis but no visceral metastasis
por: Zhu, Mingyu, et al.
Publicado: (2019)